GE Healthcare's Sofie Deal to Vertically Integrate Radiopharma Portfolio, Needham Says
MT newswire2026/10/05 19:0403:04 PM EDT, 10/05/2026 (MT Newswires) -- GE Healthcare Technologies' (GEHC) planned $945 million acquisition of Sofie Biosciences should enable it to vertically integrate its radiopharmaceuticals portfolio and adds a phase 3 asset to its pipeline, Needham said in a Monday note. With the acquisition, GEHC should be able to integrate production and distribution of its radiopharmaceuticals portfolio. Sofie's distribution network includes 15 CMO sites across the US with two coming soon, Needham analysts said, citing the firm's website. The acquisition also brings US rights to FAPI-74, Sofie's F18 fibroblast activation protein inhibitor asset that is in phase 3 and to which GE Healthcare already owns the rights outside the US. With trials for the drug estimated to complete in H2 of 2027, the analysts said they expect potential commercialization in 2029 at the earliest. Needham reiterated its buy rating on the company, with a $93 price target. Shares of GE Healthcare were up more than 2% in Monday afternoon trading. Price: 65.61, Change: +1.32, Percent Change: +2.05
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Crypto prices
More
